GlaxoSmithKline plc's (GSK) "Buy" Rating Reiterated at Beaufort Securities


's stock had its "buy" rating reaffirmed by analysts at Beaufort Securities in a research note issued on Thursday, StockTargetPrices.com reports. They currently have a GBX 1,750 target price on the stock.



from Biotech News